Ventracor Announces ‘Milestone’ FDA Approval
Medical technology company Ventracor (VCR) said today that the US Food & Drug Administration (FDA) has recommended conditional approval for the marketing of a second generation Left Ventricular Assist Device (LVAD), developed by rival company Thoratec.
Read More